The Truven Health Analytics 50 Top Cardiovascular Hospitals study identifies hospitals that achieve the best performance on a scorecard of performance measures. This year, based on comparisons between the winners and a peer group of similar high-volume hospitals that were not winners, the study found that if all cardiovascular providers performed at the level of this year’s winners, approximately 9,500 additional patients could survive, more than $1 billion could be saved, and almost 3,000 additional bypass and angioplasty patients could be complication-free. This is based on an analysis of Medicare patients; if the same standards were applied to all inpatients, the impact would be even greater.
The Truven Health Analytics 50 Top Cardiovascular Hospitals study identifies U.S. hospitals that have achieved the best performance on a balanced scorecard of performance measures. Based on comparisons between study winners and a peer group of similar hospitals that were not winners, winners are achieving better outcomes while operating more efficiently and at a lower cost. If all cardiovascular providers performed at the same level of this year’s winners, almost 8,000 additional lives could be saved; nearly 3,500 heart patients could be complication free; and more than $1.3 billion could be saved.
Published By: VersaSuite
Published Date: Aug 13, 2013
Healthcare providers do not have to live with functionality interruptions and budget strains created by an EHR that does not fit the facility. VersaSuite delivers a customizable EHR/HIS system to streamline the entire range of healthcare business processes.
Published By: Medidata
Published Date: Nov 10, 2017
Founded by physicians committed to advancing medical science, Worldwide Clinical Trials is out to change how the world experiences CROs. From early phase and bioanalytical sciences through late phase and post-approval, they provide full-service drug development services across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID) and rare diseases.